Cell-autonomous role of Presenilin in age-dependent survival of cortical interneurons.
Alzheimer’s disease
Apoptosis
Astrogliosis
Cerebral cortex
Conditional knockout mouse
Excitatory neurons
GABAergic
Interneurons
Microgliosis
Neuronal death
Journal
Molecular neurodegeneration
ISSN: 1750-1326
Titre abrégé: Mol Neurodegener
Pays: England
ID NLM: 101266600
Informations de publication
Date de publication:
10 12 2020
10 12 2020
Historique:
received:
30
06
2020
accepted:
01
12
2020
entrez:
11
12
2020
pubmed:
12
12
2020
medline:
12
10
2021
Statut:
epublish
Résumé
Mutations in the PSEN1 and PSEN2 genes are the major cause of familial Alzheimer's disease. Previous studies demonstrated that Presenilin (PS), the catalytic subunit of γ-secretase, is required for survival of excitatory neurons in the cerebral cortex during aging. However, the role of PS in inhibitory interneurons had not been explored. To determine PS function in GABAergic neurons, we generated inhibitory neuron-specific PS conditional double knockout (IN-PS cDKO) mice, in which PS is selectively inactivated by Cre recombinase expressed under the control of the endogenous GAD2 promoter. We then performed behavioral, biochemical, and histological analyses to evaluate the consequences of selective PS inactivation in inhibitory neurons. IN-PS cDKO mice exhibit earlier mortality and lower body weight despite normal food intake and basal activity. Western analysis of protein lysates from various brain sub-regions of IN-PS cDKO mice showed significant reduction of PS1 levels and dramatic accumulation of γ-secretase substrates. Interestingly, IN-PS cDKO mice develop age-dependent loss of GABAergic neurons, as shown by normal number of GAD67-immunoreactive interneurons in the cerebral cortex at 2-3 months of age but reduced number of cortical interneurons at 9 months. Moreover, age-dependent reduction of Parvalbumin- and Somatostatin-immunoreactive interneurons is more pronounced in the neocortex and hippocampus of IN-PS cDKO mice. Consistent with these findings, the number of apoptotic cells is elevated in the cerebral cortex of IN-PS cDKO mice, and the enhanced apoptosis is due to dramatic increases of apoptotic interneurons, whereas the number of apoptotic excitatory neurons is unaffected. Furthermore, progressive loss of interneurons in the cerebral cortex of IN-PS cDKO mice is accompanied with astrogliosis and microgliosis. Our results together support a cell-autonomous role of PS in the survival of cortical interneurons during aging. Together with earlier studies, these findings demonstrate a universal, essential requirement of PS in the survival of both excitatory and inhibitory neurons during aging.
Sections du résumé
BACKGROUND
Mutations in the PSEN1 and PSEN2 genes are the major cause of familial Alzheimer's disease. Previous studies demonstrated that Presenilin (PS), the catalytic subunit of γ-secretase, is required for survival of excitatory neurons in the cerebral cortex during aging. However, the role of PS in inhibitory interneurons had not been explored.
METHODS
To determine PS function in GABAergic neurons, we generated inhibitory neuron-specific PS conditional double knockout (IN-PS cDKO) mice, in which PS is selectively inactivated by Cre recombinase expressed under the control of the endogenous GAD2 promoter. We then performed behavioral, biochemical, and histological analyses to evaluate the consequences of selective PS inactivation in inhibitory neurons.
RESULTS
IN-PS cDKO mice exhibit earlier mortality and lower body weight despite normal food intake and basal activity. Western analysis of protein lysates from various brain sub-regions of IN-PS cDKO mice showed significant reduction of PS1 levels and dramatic accumulation of γ-secretase substrates. Interestingly, IN-PS cDKO mice develop age-dependent loss of GABAergic neurons, as shown by normal number of GAD67-immunoreactive interneurons in the cerebral cortex at 2-3 months of age but reduced number of cortical interneurons at 9 months. Moreover, age-dependent reduction of Parvalbumin- and Somatostatin-immunoreactive interneurons is more pronounced in the neocortex and hippocampus of IN-PS cDKO mice. Consistent with these findings, the number of apoptotic cells is elevated in the cerebral cortex of IN-PS cDKO mice, and the enhanced apoptosis is due to dramatic increases of apoptotic interneurons, whereas the number of apoptotic excitatory neurons is unaffected. Furthermore, progressive loss of interneurons in the cerebral cortex of IN-PS cDKO mice is accompanied with astrogliosis and microgliosis.
CONCLUSION
Our results together support a cell-autonomous role of PS in the survival of cortical interneurons during aging. Together with earlier studies, these findings demonstrate a universal, essential requirement of PS in the survival of both excitatory and inhibitory neurons during aging.
Identifiants
pubmed: 33302995
doi: 10.1186/s13024-020-00419-y
pii: 10.1186/s13024-020-00419-y
pmc: PMC7731773
doi:
Substances chimiques
Presenilin-1
0
Presenilins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
72Subventions
Organisme : NINDS NIH HHS
ID : R01 NS041783
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG063520
Pays : United States
Références
Genesis. 2000 Jan;26(1):5-8
pubmed: 10660668
Brain Pathol. 2020 Mar;30(2):345-363
pubmed: 31491047
Neuron. 2020 Nov 25;108(4):676-690.e8
pubmed: 32891188
Neuron. 2001 Sep 13;31(5):713-26
pubmed: 11567612
Methods Mol Biol. 2013;1004:91-113
pubmed: 23733572
J Neurosci. 1996 Dec 1;16(23):7513-25
pubmed: 8922407
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16807-12
pubmed: 21949377
Cell. 1997 May 16;89(4):629-39
pubmed: 9160754
Mol Neurodegener. 2008 Jan 08;3:2
pubmed: 18182109
J Comp Neurol. 2000 Sep 4;424(4):607-27
pubmed: 10931484
Mol Neurodegener. 2017 Jun 15;12(1):48
pubmed: 28619096
Neuron. 2015 Mar 4;85(5):967-81
pubmed: 25741723
Brain Res. 1987 Aug 18;418(1):164-9
pubmed: 3311290
J Biol Chem. 2012 Jun 8;287(24):20356-68
pubmed: 22505716
Brain Res Mol Brain Res. 1996 Sep 5;41(1-2):36-49
pubmed: 8883932
Mol Med. 2000 Oct;6(10):878-91
pubmed: 11126202
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
J Comp Neurol. 2010 Feb 1;518(3):389-404
pubmed: 19950390
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):403-9
pubmed: 17197420
J Neurosci. 1996 May 15;16(10):3311-21
pubmed: 8627368
Neuron. 2004 Apr 8;42(1):23-36
pubmed: 15066262
Curr Opin Otolaryngol Head Neck Surg. 2009 Jun;17(3):187-93
pubmed: 19417662
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8162-7
pubmed: 15148382
Trends Neurosci. 2013 Mar;36(3):152-62
pubmed: 23254296
J Neurosci. 2014 Nov 26;34(48):15912-22
pubmed: 25429133
Acta Neuropathol. 1991;81(4):388-95
pubmed: 2028743
Nat Rev Neurosci. 2004 Oct;5(10):793-807
pubmed: 15378039
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10863-8
pubmed: 11517342
Nature. 1980 Nov 20;288(5788):279-80
pubmed: 6107862
Semin Ultrasound CT MR. 2010 Jun;31(3):196-219
pubmed: 20483389
Trends Neurosci. 1998 Jul;21(7):273-8
pubmed: 9683315
Neuron. 2011 Sep 22;71(6):995-1013
pubmed: 21943598
Front Neuroanat. 2018 Oct 23;12:83
pubmed: 30405363
Nature. 2000 Jun 8;405(6787):689-94
pubmed: 10864326
Neuroscience. 2005;134(2):525-38
pubmed: 15961235
Neuron. 2018 Oct 24;100(2):294-313
pubmed: 30359598
Curr Alzheimer Res. 2017;14(1):30-39
pubmed: 27539596
Nat Rev Neurosci. 2016 Dec;17(12):777-792
pubmed: 27829687
Development. 2000 Jun;127(12):2593-606
pubmed: 10821758
Nat Med. 1996 Feb;2(2):224-9
pubmed: 8574969
Nat Neurosci. 2007 Nov;10(11):1355-60
pubmed: 17965655
Nature. 2009 Jul 30;460(7255):632-6
pubmed: 19641596
PLoS One. 2010 Apr 15;5(4):e10195
pubmed: 20419112
Brain Res Rev. 2010 May;63(1-2):189-211
pubmed: 19944719
J Neurosci. 2010 Dec 15;30(50):16796-808
pubmed: 21159951
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15091-6
pubmed: 23918386
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8973-8
pubmed: 24889619
J Neurosci. 2009 Jun 3;29(22):7290-301
pubmed: 19494151
Exp Neurol. 1998 Mar;150(1):14-20
pubmed: 9514829
Neurosci Lett. 2014 Apr 30;566:137-41
pubmed: 24569123
J Biol Chem. 2004 Nov 5;279(45):46907-14
pubmed: 15345711
Neuroscience. 1999;92(2):515-32
pubmed: 10408601
Genetics. 2017 Jul;206(3):1479-1493
pubmed: 28495961
Hippocampus. 1996;6(4):347-470
pubmed: 8915675
Neuron. 2017 Nov 15;96(4):796-807.e6
pubmed: 29056298
Exp Neurol. 2010 Jun;223(2):347-50
pubmed: 19559700
J Neurochem. 2010 Dec;115(5):1215-21
pubmed: 20854432
Neuroscience. 1997 Oct;80(4):1113-25
pubmed: 9284064
Neuron. 2016 Jul 20;91(2):260-92
pubmed: 27477017